Journal of Cardiovascular Translational Research

, Volume 3, Issue 6, pp 663–673 | Cite as

Shared Desmosome Gene Findings in Early and Late Onset Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

  • Boon Yew Tan
  • Rahul Jain
  • A. Dénise den Haan
  • Yan Chen
  • Darshan Dalal
  • Harikrishna Tandri
  • Nuria Amat-Alarcon
  • Amy Daly
  • Crystal Tichnell
  • Cynthia James
  • Hugh Calkins
  • Daniel P. Judge
Article

Abstract

Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an inherited form of cardiomyopathy with low penetrance and variable expressivity. Dominant mutations and rare polymorphisms in desmosome genes are frequently identified. We reasoned that individuals with earlier onset disease would have more frequent desmosome gene mutations and rare polymorphisms. Three groups were compared: Young with symptoms attributable to ARVD/C or a diagnosis of ARVD/C at age of 21 years or earlier, Middle with first symptoms or diagnosis age of 22–49 years, and Late with first symptoms or diagnosis at age of 50 or more years. deoxyribonucleic acid (DNA) sequence analysis was performed on five cardiac desmosome genes, and the presence of mutations and rare missense polymorphisms was compared among the three groups. In the entire Young cohort, 20 (67%) had one or more cardiac desmosome gene mutations. The prevalence of cardiac desmosome gene mutations was similar in the Middle (48%) and Late (53%) cohorts (P = 0.23). Similar numbers of individuals in each cohort had more than one desmosome gene mutation, although the numbers are too small for statistical comparisons. The prevalence of certain rare missense DNA variants was not different among the cohorts (P = 0.71), yet these rare missense alleles were more prevalent in the overall study cohort of 112 ARVD/C participants compared to 100 race-matched controls (P = 0.027). The presence of these variants did not associate with the age of onset of ARVD/C or ventricular tachycardia. These findings highlight the complex interplay of environmental and genetic factors contributing to this condition.

Keywords

Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) Genetics Sudden cardiac death Desmosome 

Supplementary material

12265_2010_9224_MOESM1_ESM.docx (42 kb)
Table S1Clinical and genetic characteristics of participants. (DOC 42.3 kb)
12265_2010_9224_MOESM2_ESM.doc (41 kb)
Fig. S1Conservation at sites of novel mutations in the Young cohort. Conservation of the mutated amino acid in five novel missense mutations. Amino acids are represented by their standard abbreviations (E Glutamate, K Lysine, G Glycine, T Threonine). ↓ indicates site of mutation. Species are shown by their standard nomenclature. (DOC 41.0 kb)
12265_2010_9224_MOESM3_ESM.doc (32 kb)
Fig. S2Conservation at sites of novel mutations in the Late cohort. Conservation of the mutated amino acid in three novel missense mutations. Amino acids are represented by their standard abbreviations (D aspartate, E glutamate, V valine). ↓ indicates site of mutation. Species are shown by their standard nomenclature. (DOC 31.5 kb)

References

  1. 1.
    Awad, M. M., Calkins, H., & Judge, D. P. (2008). Mechanisms of disease: Molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nature Clinical Practice. Cardiovascular Medicine, 5, 258–267.CrossRefPubMedGoogle Scholar
  2. 2.
    Corrado, D., & Thiene, G. (2006). Arrhythmogenic right ventricular cardiomyopathy/dysplasia: Clinical impact of molecular genetic studies. Circulation, 113, 1634–1637.CrossRefPubMedGoogle Scholar
  3. 3.
    Dalal, D., Molin, L. H., Piccini, J., Tichnell, C., James, C., Bomma, C., et al. (2006). Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Circulation, 113, 1641–1649.CrossRefPubMedGoogle Scholar
  4. 4.
    Gerull, B., Heuser, A., Wichter, T., Paul, M., Basson, C. T., McDermott, D. A., et al. (2004). Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nature Genetics, 36, 1162–1164.CrossRefPubMedGoogle Scholar
  5. 5.
    Awad, M. M., Dalal, D., Cho, E., Amat-Alarcon, N., James, C., Tichnell, C., et al. (2006). DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy. American Journal of Human Genetics, 79, 136–142.CrossRefPubMedGoogle Scholar
  6. 6.
    Syrris, P., Ward, D., Evans, A., Asimaki, A., Gandjbakhch, E., Sen-Chowdhry, S., et al. (2006). Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. American Journal of Human Genetics, 79, 978–984.CrossRefPubMedGoogle Scholar
  7. 7.
    Asimaki, A., Syrris, P., Wichter, T., Matthias, P., Saffitz, J. E., & McKenna, W. J. (2007). A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. American Journal of Human Genetics, 81, 964–973.CrossRefPubMedGoogle Scholar
  8. 8.
    McKoy, G., Protonotarios, N., Crosby, A., Tsatsopoulou, A., Anastasakis, A., Coonar, A., et al. (2000). Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet, 355, 2119–2124.CrossRefPubMedGoogle Scholar
  9. 9.
    Sen-Chowdhry, S., Syrris, P., & McKenna, W. J. (2005). Genetics of right ventricular cardiomyopathy. Journal of Cardiovascular Electrophysiology, 16, 927–935.CrossRefPubMedGoogle Scholar
  10. 10.
    Awad, M. M., Dalal, D., Tichnell, C., James, C., Tucker, A., Abraham, T., et al. (2006). Recessive arrhythmogenic right ventricular dysplasia due to novel cryptic splice mutation in PKP2. Human Mutation, 27, 1157.CrossRefPubMedGoogle Scholar
  11. 11.
    den Haan, A. D., Tan, B. Y., Zikusoka, M. N., Llado, L. I., Jain, R., Daly, A., et al. (2009). Comprehensive desmosome mutation analysis in North Americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation: Cardiovascular Genetics, 2, 428–435.CrossRefGoogle Scholar
  12. 12.
    Dalal, D., Nasir, K., Bomma, C., Prakasa, K., Tandri, H., Piccini, J., et al. (2005). Arrhythmogenic right ventricular dysplasia: A United States experience. Circulation, 112, 3823–3832.CrossRefPubMedGoogle Scholar
  13. 13.
    Taylor, G. P. (2009). The pathology of arrhythmogenic right ventricular cardiomyopathy. In A. R. Redington, G. S. VanArsdell, & R. H. Anderson (Eds.), Congenital diseases in the right heart (pp. 125–129). London: Springer.CrossRefGoogle Scholar
  14. 14.
    Dalal, D., James, C., Devanagondi, R., Tichnell, C., Tucker, A., Prakasa, K., et al. (2006). Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Journal of the American College of Cardiology, 48, 1416–1424.CrossRefPubMedGoogle Scholar
  15. 15.
    Sen-Chowdhry, S., Syrris, P., & McKenna, W. J. (2007). Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Journal of the American College of Cardiology, 50, 1813–1821.CrossRefPubMedGoogle Scholar
  16. 16.
    Frigo, G., Bauce, B., Basso, C., & Nava, A. (2006). Late-onset arrhythmogenic right ventricular cardiomyopathy. Journal of Cardiovascular Medicine (Hagerstown), 7, 74–76.CrossRefGoogle Scholar
  17. 17.
    McKenna, W. J., Thiene, G., Nava, A., Fontaliran, F., Blomstrom-Lundqvist, C., Fontaine, G., et al. (1994). Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. British Heart Journal, 71, 215–218.CrossRefPubMedGoogle Scholar
  18. 18.
    Christensen, A. H., Benn, M., Tybjaerg-Hansen, A., Haunso, S., & Svendsen, J. H. (2010). Missense variants in plakophilin-2 in arrhythmogenic right ventricular cardiomyopathy patients–disease-causing or innocent bystanders? Cardiology, 115, 148–154.CrossRefPubMedGoogle Scholar
  19. 19.
    Posch, M. G., Posch, M. J., Geier, C., Erdmann, B., Mueller, W., Richter, A., et al. (2008). A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy. Molecular Genetics and Metabolism, 95, 74–80.CrossRefPubMedGoogle Scholar
  20. 20.
    Nishi, H., Kimura, A., Harada, H., Adachi, K., Koga, Y., Sasazuki, T., et al. (1994). Possible gene dose effect of a mutant cardiac beta-myosin heavy chain gene on the clinical expression of familial hypertrophic cardiomyopathy. Biochemical and Biophysical Research Communications, 200, 549–556.CrossRefPubMedGoogle Scholar
  21. 21.
    Ingles, J., Doolan, A., Chiu, C., Seidman, J., Seidman, C., & Semsarian, C. (2005). Compound and double mutations in patients with hypertrophic cardiomyopathy: Implications for genetic testing and counselling. Journal of Medical Genetics, 42, e59.CrossRefPubMedGoogle Scholar
  22. 22.
    Morita, H., Rehm, H. L., Menesses, A., McDonough, B., Roberts, A. E., Kucherlapati, R., et al. (2008). Shared genetic causes of cardiac hypertrophy in children and adults. The New England Journal of Medicine, 358, 1899–1908.CrossRefPubMedGoogle Scholar
  23. 23.
    Bhuiyan, Z. A., Jongbloed, J. D., van der Smagt, J., Lombardi, P. M., Wiesfeld, A. C., Nelen, M., et al. (2009). Desmoglein-2 and desmocollin-2 mutations in dutch arrhythmogenic right ventricular dysplasia/cardiomypathy patients: Results from a multicenter study. Circulation: Cardiovascular Genetics, 2, 418–427.CrossRefGoogle Scholar
  24. 24.
    Fressart, V., Duthoit, G., Donal, E., Probst, V., Deharo, J. C., Chevalier, P., et al. (2010). Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: Spectrum of mutations and clinical impact in practice. Europace, 12, 861–868.CrossRefPubMedGoogle Scholar
  25. 25.
    Barahona-Dussault, C., Benito, B., Campuzano, O., Iglesias, A., Leung, T. L., Robb, L., et al. (2010). Role of genetic testing in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Clinical Genetics, 77, 37–48.CrossRefPubMedGoogle Scholar
  26. 26.
    Basso, C., Thiene, G., Corrado, D., Angelini, A., Nava, A., & Valente, M. (1996). Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation, 94, 983–991.PubMedGoogle Scholar
  27. 27.
    Thiene, G., Nava, A., Corrado, D., Rossi, L., & Pennelli, N. (1988). Right ventricular cardiomyopathy and sudden death in young people. The New England Journal of Medicine, 318, 129–133.CrossRefPubMedGoogle Scholar
  28. 28.
    Aronow, W. S., Mercando, A. D., & Epstein, S. (1995). Usefulness of an abnormal signal-averaged electrocardiogram for predicting cardiac death in elderly persons without heart disease. The American Journal of Cardiology, 75, 1273–1274.CrossRefPubMedGoogle Scholar
  29. 29.
    Crotti, L., Lundquist, A. L., Insolia, R., Pedrazzini, M., Ferrandi, C., De Ferrari, G. M., et al. (2005). KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. Circulation, 112, 1251–1258.CrossRefPubMedGoogle Scholar
  30. 30.
    Xu, T., Yang, Z., Vatta, M., Rampazzo, A., Beffagna, G., Pilichou, K., et al. (2010). Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. Journal of the American College of Cardiology, 55, 587–597.CrossRefPubMedGoogle Scholar
  31. 31.
    Marcus, F. I., McKenna, W. J., Sherrill, D., Basso, C., Bauce, B., Bluemke, D. A., et al. (2010). Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed modification of the task force criteria. Circulation, 121, 1533–1541.CrossRefPubMedGoogle Scholar
  32. 32.
    Cox, M. G. P. J., van der Smagt, J. J., Noorman, M., Wiesfeld, A. C., Volders, P. G. A., van Langen, I. M., et al. (2010). Arrhythmogenic right ventricular dysplasia/cardiomyopathy diagnostic task force criteria: Impact of new task force criteria. Circulation: Arrhythmia Electrophysiology, 3, 126–133.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Boon Yew Tan
    • 1
    • 2
  • Rahul Jain
    • 1
  • A. Dénise den Haan
    • 1
  • Yan Chen
    • 1
  • Darshan Dalal
    • 1
  • Harikrishna Tandri
    • 1
  • Nuria Amat-Alarcon
    • 1
  • Amy Daly
    • 1
  • Crystal Tichnell
    • 1
  • Cynthia James
    • 1
  • Hugh Calkins
    • 1
  • Daniel P. Judge
    • 1
    • 3
  1. 1.Department of Medicine/CardiologyJohns Hopkins University School of MedicineBaltimoreUSA
  2. 2.Department of CardiologyNational Heart CentreSingaporeSingapore
  3. 3.Division of CardiologyJohns Hopkins UniversityBaltimoreUSA

Personalised recommendations